Y-mAbs Therapeutics
YMAB
#8252
Rank
โ‚ฌ0.16 B
Marketcap
3,58ย โ‚ฌ
Share price
-1.45%
Change (1 day)
-74.93%
Change (1 year)

EPS for Y-mAbs Therapeutics (YMAB)

EPS in 2023 (TTM): -0,88ย โ‚ฌ

According to Y-mAbs Therapeutics 's latest financial reports the company's current EPS (TTM) is -0,78ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -1,92ย โ‚ฌ a decrease over its 2021 EPS that were of -1,09ย โ‚ฌ.

EPS history for Y-mAbs Therapeutics from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,88ย โ‚ฌ-54.17%
2022-1,92ย โ‚ฌ75.81%
2021-1,09ย โ‚ฌ-58.25%
2020-2,61ย โ‚ฌ28.57%
2019-2,03ย โ‚ฌ67.32%
2018-1,22ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,92ย โ‚ฌ 144.94%๐Ÿ‡บ๐Ÿ‡ธ USA